| |
Progesterone group N = 102
|
Placebo group N = 97
| |
|---|
|
Early fetal loss (n)
|
2 (2%)
|
4 (4.1%)
|
0.372
|
|
Gestational age at delivery (weeks)
|
34.7 ± 3.6
|
34.5 ± 4.5
|
0.626
|
|
Term births (n)
|
> 37 weeks
|
25 (24.5%)
|
27 (27.8%)
|
0.594
|
|
Preterm births (n)
|
< 37 weeks
|
75 (73.5%)
|
66 (68%)
|
0.551
|
|
< 34 weeks
|
21 (20.6%)
|
21 (21.6%)
|
0.649
|
|
< 32 weeks
|
9 (8.8%)
|
12 (12.4%)
|
0.46
|
|
< 30 weeks
|
5 (4.9%)
|
7 (7.2%)
|
0.516
|
|
< 28 weeks
|
5 (4.9%)
|
3 (3.1%)
|
0.555
|
- Data is expressed either as a mean ± SD or n (%)
- Preterm births are all spontaneous births, except for two patients in the progesterone group who had iatrogenic termination < 37 weeks because of severe pre-eclampsia with no neonatal morbidity or mortality
